Can MEI Pharma Survive?
After MEI Pharma cratered in the wake of disappointing results from one of its studies, analysts are making their calls on where the stock looks to go from here.
All Work
Chris Lange
Are Steel and Metal Stocks Forming a Bottom?
Many of the key steel and aluminum stocks have sold off sharply from their highs. Despite this poor performance, is it possible that the steel and aluminum giants are trying to find a bottom?
Will India Be the Next Major Driver for Alternative Energy?
Industry watchers and alternative energy investors are wondering which markets will be the next major growth engine. It turns out that India could be the next major growth catalyst.
Can BlackBerry Have Positive Free Cash Flow?
BlackBerry Ltd.Blackberry Limited (NASDAQ: BBRY) has been battered and it seems nearly impossible to imagine that the troubled smartphone player will have positive earnings again. That being said, is it possible that BlackBerry could…
Should Analyst Upgrades Value Facebook as Much as Wal-Mart?
A couple of investment banks have weighed in on Facebook. Should the social media powerhouse be valued the same as Wal-Mart?
Is There More Hope Than Reality in Molycorp and Rare Earth Gains?
Rare earth elements are back in focus after CBS's weekly news show "60 Minutes" reported on them in its show that aired Sunday night.
Why 1 Analyst Is Now So Positive on Kinder Morgan
In the months after everyone jumped ship on the energy sector due to falling oil prices, independent research firm Argus thinks it might be time to get back on board.
7 Key Earnings Reports to Watch in the Week Ahead
24/7 Wall St. has put together a preview of some of the larger companies reporting in the middle of March, including BlackBerry and Lululemon.
Have Herbalife Shares Bottomed?
Shares of Herbalife may still be way down from when activist investor Bill Ackman first publicly went after the maker of vitamins and health products, but they have also bounced handily of late.
Apigee Files for IPO
Software company Apigee Corp. has filed with the U.S. Securities and Exchange Commission for an initial public offering.
Commercial Credit Files for IPO
Commercial Credit Inc. has filed a Form S-1 with the U.S. Securities and Exchange Commission for an initial public offering.
How Analysts See Nike After Earnings
24/7 Wall St. wanted to see whether analysts were changing their views on Nike in the wake of mixed fiscal third-quarter financial results.
Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec
Friday morning, Biogen Idec announced positive results related to its Alzheimer's study. Any real Alzheimer's drug certainly would make the blockbuster category.
How Large Is Prothena’s Market Opportunity?
Prothena has announced positive results from a Phase 1 study of a monoclonal antibody for the potential treatment of Parkinson's disease and other related synucleinopathies.
Why Even Nike Hates Foreign Currencies Right Now
Nike Inc. (NYSE: NKE) reported its fiscal third-quarter financial results on Thursday after the close of trading.
Does Banker Lawsuit Put Cliffs at Further Risk?
The Bank of Nova Scotia is now reportedly suing Cliffs for roughly $53 million related to equipment loans tied to Canada.
Elon Musk Makes Tesla Into Knight Rider
The idea behind the latest software update for the Tesla Model S sedan is that it will add more safety features, as well as some other neat features to draw in more customers.
Big eBay Downgrade Tied to Risk Around Growth and Market Share
eBay may be in the process of splitting up, but at least one more analyst is far from positive about the e-commerce and auction giant.
With Wireless Electricity, Is Energous the Next Big Thing?
ThinkstockIn this day and age, everyone is moving to cut the cords and go wireless. The problem is that we all still have to charge our wireless devices. This is one of the most…
How the Tekmira Secondary Offering Could Help the Company
Tekmira Pharmaceuticals, one of the top names in the Ebola drug arena, is now about to raise a significant amount of capital in a secondary offering.